Plasma glucagon quantification with an enzyme‐linked immunosorbent assay (ELISA) displayed a higher glucagon release in the hypoglycemia group starting at 3‐h post‐administration, consistent with the subsequent sustained normoglycemia levels. The gene discussed is GCG; the disease is Hypoglycemia.